Recursion Pharmaceuticals, Inc. (RXRX) dividend history
RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/302% below fair value
$2.90−0.28 (-8.79%)
Close on Nov 16, 2026Market cap $1.56BP/E –Yield –
Dividends
Recursion Pharmaceuticals has not reported a dividend
No dividend per share appears in Recursion Pharmaceuticals's annual filings since fiscal 2018.
See a number that looks wrong?